Montelukast sodium and Conjunctivitis - a phase IV clinical study of FDA data

Summary:

Conjunctivitis is reported as a side effect among people who take Montelukast sodium (montelukast sodium), especially for people who are female, 50-59 old, also take Epinephrine, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Conjunctivitis when taking Montelukast sodium. It is created by eHealthMe based on reports of 24,779 people who have side effects when taking Montelukast sodium from the FDA, and is updated regularly.

What is Montelukast sodium?

Montelukast sodium has active ingredients of montelukast sodium. It is often used in asthma. eHealthMe is studying from 26,095 Montelukast sodium users. Check the latest studies of Montelukast sodium.

What is Conjunctivitis?

Conjunctivitis (pink eye) is found to be associated with 1,298 drugs and 1,644 conditions by eHealthMe. Check the latest studies of Conjunctivitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

24,779 people reported to have side effects when taking Montelukast sodium.
Among them, 47 people (0.19%) have Conjunctivitis.

Could Montelukast sodium cause Conjunctivitis?

Among these 47 people:

What is the gender of people who have Conjunctivitis when taking Montelukast sodium? *

  • female: 73.91 %
  • male: 26.09 %

What is the age of people who have Conjunctivitis when taking Montelukast sodium? *

  • 0-1: 0.0 %
  • 2-9: 2.94 %
  • 10-19: 5.88 %
  • 20-29: 2.94 %
  • 30-39: 14.71 %
  • 40-49: 29.41 %
  • 50-59: 29.41 %
  • 60+: 14.71 %

What are other drugs people take besides Montelukast sodium? *

  1. Epinephrine: 18 people, 38.30%
  2. Acetaminophen: 16 people, 34.04%
  3. Dupixent: 15 people, 31.91%
  4. Albuterol Sulfate: 13 people, 27.66%
  5. Gabapentin: 11 people, 23.40%
  6. Lidocaine: 11 people, 23.40%
  7. Symbicort: 11 people, 23.40%
  8. Levothyroxine Sodium: 10 people, 21.28%
  9. Azelastine Hydrochloride: 10 people, 21.28%
  10. Diphenhydramine Hydrochloride: 9 people, 19.15%

What are other side effects people have besides Conjunctivitis? *

  1. Sinusitis (inflammation of sinus): 15 people, 31.91%
  2. Nausea (feeling of having an urge to vomit): 13 people, 27.66%
  3. Weakness: 11 people, 23.40%
  4. Urinary Tract Infection: 11 people, 23.40%
  5. Viral Infection: 10 people, 21.28%
  6. Headache (pain in head): 10 people, 21.28%
  7. Chills (felling of cold): 10 people, 21.28%
  8. Malaise (a feeling of general discomfort or uneasiness): 9 people, 19.15%
  9. Infusion Site Erythema (reddening of the skin at infusion site): 9 people, 19.15%
  10. Infection: 9 people, 19.15%

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 16 people, 34.04%
  2. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 9 people, 19.15%
  3. Primary Immunodeficiency Syndrome: 4 people, 8.51%
  4. Urticaria (rash of round, red welts on the skin that itch intensely): 4 people, 8.51%
  5. Hypersensitivity: 4 people, 8.51%
  6. Allergic Rhinitis: 3 people, 6.38%
  7. Ocular Surface Disease (disorders of the surface of the cornea): 2 people, 4.26%
  8. Nerve Compression: 2 people, 4.26%
  9. Blepharitis (chronic inflammation of the eyelid): 2 people, 4.26%
  10. Multiple Allergies (allergy to multiple agents): 2 people, 4.26%

* Approximation only. Some reports may have incomplete information.

Do you take Montelukast sodium and have Conjunctivitis?

- Check whether Conjunctivitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Montelukast sodium:

Conjunctivitis treatments and more:

How severe was Conjunctivitis and when was it recovered:

Expand to all the drugs that have ingredients of montelukast sodium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Montelukast sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Conjunctivitis:

Browse all the conditions that are associated with Conjunctivitis:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on montelukast sodium (the active ingredients of Montelukast sodium) and Montelukast sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: